Clinical Trial Update: The PENTO Protocol in Medication-related Osteonecrosis of the Jaw [Phase 2]

View source ↗

Summary

Phase 2 trial update for the PENTO Protocol addressing medication-related osteonecrosis of the jaw (MRONJ).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medication-related Osteonecrosis of the Jaw

Snippet

Sponsor: University Hospital, Limoges | Conditions: Medication-related Osteonecrosis of the Jaw (MRONJ) | Phase 2 | Status: UNKNOWN